Skip to main content

Table 1 Inclusion criteria. Inclusion criteria of the PURIAM110 trial

From: The efficacy and safety study of dietary supplement PURIAM110 on non-insulin taking Korean adults in the stage of pre-diabetes and diabetes mellitus: protocol for a randomized, double-blind, placebo-controlled, and multicenter trial-pilot study

Inclusion criteria

1.

Both gender between the ages of 18-69 years, eligible for study through screening test prior to the enrolment.

2.

Able and willing to perform the study protocol and participate throughout the entire trial period(Screening, baseline, 3, 6 weeks, follow up(if needed)).

3.

Participants who understood the risks and benefits of the study and signed a written informed consent.

4.

Among individuals not under diabetes mellitus treatment, whose random glucose concentration is 110~250 mg/dL measured with Accu-Chek®(Roche, Germany) glucometer within 3 weeks prior to participation.

4.1.

fasting plasma glucose concentration is 100-190 mg/dL or

4.2.

2- hour plasma glucose concentration* is 130-250 mg/dL(

* venous plasma glucose 2-hour after ingestion of 75 g oral glucose load; DIASOL-S LIQ. [Glucose] Taejoon Pharm.)